Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan

Clinical trial NCT02941367 · COMPLETED

Trial details

NCT number

NCT02941367

Sponsor

Sanofi

Status

COMPLETED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2017-02-23

Primary completion

2017-08-04

Enrollment

184

View on ClinicalTrials.gov